Association of Antibiotics and Other Drugs with Clinical Outcomes in Metastatic Melanoma Patients Treated with Immunotherapy

Table 2

Comparison of the time-to-discontinuation (TTD) in days among patients who received concomitant medications (CI = 95%).

Medication received	Mean	Std. deviation	Lower bound	Upper bound
Antibiotics
No	332.4	26.2	281.2	383.7
Yes	260.5	63.4	136.2	384.8
NSAIDs
No	331.9	45.7	242.3	421.5
Yes	310.2	28.8	253.8	366.6
Statins
No	339.6	33.2	274.5	404.7
Yes	282.4	34.2	215.4	349.4
PPI
No	346.8	31.1	285.8	407.8
Yes	266.1	37.8	191.9	340.2
Steroids
No	339.4	31.1	278.5	400.3
Yes	285.9	38.0	211.4	360.5

NSAIDs, nonsteroidal anti-inflammatory drugs; PPI, proton-pump inhibitor.